"I am excited to be part of a pioneering team bringing a new modality like targeted protein degradation to patients with new medicines that will make a difference in their lives.
I love to build companies and mentor others to realize their potential."

Ellen Chiniara, JD

Chief Legal Officer and Corporate Secretary

Prior to Kymera, Ellen served as Executive Vice President, Chief Legal Officer and Corporate Secretary of Alexion Pharmaceuticals, where she was responsible for all legal, intellectual property and governance matters, and was the executive sponsor of the Corporate Social Responsibility program, until the company’s acquisition by AstraZeneca in 2021. In this role, she built and transformed the legal function, mission, and culture at the company by focusing on solutions, developing and mentoring talent, and implementing new technology and infrastructure. Before Alexion, Ellen was General Counsel at Alere, Inc., a point-of-care diagnostics company, where she spent over a decade managing various legal, government affairs, and governance functions through rapid growth and significant acquisitions globally. Earlier in her career, she was responsible for the legal function of the US neurology division at Serono and was a Partner at the law firm Hale and Dorr LLP.

Ellen currently serves as a member of the Board of Directors at Compass Therapeutics. She graduated magna cum laude from Bryn Mawr College and earned her Juris Doctor from Stanford University School of Law.

More Information
Key Facts